ID   ADAS_HUMAN              Reviewed;         658 AA.
AC   O00116; A5D8U9; Q2TU35;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   12-APR-2017, entry version 155.
DE   RecName: Full=Alkyldihydroxyacetonephosphate synthase, peroxisomal;
DE            Short=Alkyl-DHAP synthase;
DE            EC=2.5.1.26;
DE   AltName: Full=Aging-associated gene 5 protein;
DE   AltName: Full=Alkylglycerone-phosphate synthase;
DE   Flags: Precursor;
GN   Name=AGPS; ORFNames=AAG5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=9187299; DOI=10.1016/S0005-2760(97)00014-3;
RA   de Vet E.C.J.M., van den Broek B.T.E., van den Bosch H.;
RT   "Nucleotide sequence of human alkyl-dihydroxyacetonephosphate synthase
RT   cDNA reveals the presence of a peroxisomal targeting signal 2.";
RL   Biochim. Biophys. Acta 1346:25-29(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kim J.W.;
RT   "Identification of a human aging-associated gene.";
RL   Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-102 AND LYS-347, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65 AND THR-74, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65 AND THR-74, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [11]
RP   VARIANT RCDP3 HIS-419.
RX   PubMed=9553082; DOI=10.1074/jbc.273.17.10296;
RA   de Vet E.C.J.M., Ijlst L., Oostheim W., Wanders R.J.A.,
RA   van den Bosch H.;
RT   "Alkyl-dihydroxyacetonephosphate synthase. Fate in peroxisome
RT   biogenesis disorders and identification of the point mutation
RT   underlying a single enzyme deficiency.";
RL   J. Biol. Chem. 273:10296-10301(1998).
RN   [12]
RP   VARIANTS RCDP3 ILE-309 AND PRO-469.
RX   PubMed=11152660; DOI=10.1093/hmg/10.2.127;
RA   Thai T.P., Rodemer C., Jauch A., Hunziker A., Moser A., Gorgas K.,
RA   Just W.W.;
RT   "Impaired membrane traffic in defective ether lipid biosynthesis.";
RL   Hum. Mol. Genet. 10:127-136(2001).
RN   [13]
RP   VARIANTS RCDP3 GLN-182; LYS-471 AND MET-568, AND CHARACTERIZATION OF
RP   VARIANTS RCDP3 GLN-182; LYS-471 AND MET-568.
RX   PubMed=21990100; DOI=10.1002/humu.21623;
RA   Itzkovitz B., Jiralerspong S., Nimmo G., Loscalzo M., Horovitz D.D.,
RA   Snowden A., Moser A., Steinberg S., Braverman N.;
RT   "Functional characterization of novel mutations in GNPAT and AGPS,
RT   causing rhizomelic chondrodysplasia punctata (RCDP) types 2 and 3.";
RL   Hum. Mutat. 33:189-197(2012).
CC   -!- FUNCTION: Catalyzes the exchange of an acyl for a long-chain alkyl
CC       group and the formation of the ether bond in the biosynthesis of
CC       ether phospholipids. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: 1-acyl-glycerone 3-phosphate + a long-chain
CC       alcohol = an alkyl-glycerone 3-phosphate + a long-chain acid
CC       anion.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- PATHWAY: Glycerolipid metabolism; ether lipid biosynthesis.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9BQQ3:GORASP1; NbExp=5; IntAct=EBI-2838732, EBI-2561458;
CC   -!- SUBCELLULAR LOCATION: Peroxisome membrane. Note=Localized to the
CC       inner aspect of the peroxisomal membrane.
CC   -!- DISEASE: Rhizomelic chondrodysplasia punctata 3 (RCDP3)
CC       [MIM:600121]: A form of rhizomelic chondrodysplasia punctata, a
CC       disease characterized by severely disturbed endochondral bone
CC       formation, rhizomelic shortening of femur and humerus, vertebral
CC       disorders, dwarfism, cataract, cutaneous lesions, facial
CC       dysmorphism, and severe mental retardation with spasticity.
CC       {ECO:0000269|PubMed:11152660, ECO:0000269|PubMed:21990100,
CC       ECO:0000269|PubMed:9553082}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the FAD-binding oxidoreductase/transferase
CC       type 4 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y09443; CAA70591.1; -; mRNA.
DR   EMBL; AY544121; AAT11152.1; -; mRNA.
DR   EMBL; AK314259; BAG36924.1; -; mRNA.
DR   EMBL; BC141820; AAI41821.1; -; mRNA.
DR   CCDS; CCDS2275.1; -.
DR   RefSeq; NP_003650.1; NM_003659.3.
DR   UniGene; Hs.516543; -.
DR   ProteinModelPortal; O00116; -.
DR   SMR; O00116; -.
DR   BioGrid; 114110; 27.
DR   IntAct; O00116; 16.
DR   STRING; 9606.ENSP00000264167; -.
DR   SwissLipids; SLP:000000611; -.
DR   iPTMnet; O00116; -.
DR   PhosphoSitePlus; O00116; -.
DR   SwissPalm; O00116; -.
DR   BioMuta; AGPS; -.
DR   EPD; O00116; -.
DR   MaxQB; O00116; -.
DR   PaxDb; O00116; -.
DR   PeptideAtlas; O00116; -.
DR   PRIDE; O00116; -.
DR   Ensembl; ENST00000264167; ENSP00000264167; ENSG00000018510.
DR   GeneID; 8540; -.
DR   KEGG; hsa:8540; -.
DR   UCSC; uc002ull.3; human.
DR   CTD; 8540; -.
DR   DisGeNET; 8540; -.
DR   GeneCards; AGPS; -.
DR   HGNC; HGNC:327; AGPS.
DR   HPA; HPA030209; -.
DR   HPA; HPA030210; -.
DR   HPA; HPA030211; -.
DR   MalaCards; AGPS; -.
DR   MIM; 600121; phenotype.
DR   MIM; 603051; gene.
DR   neXtProt; NX_O00116; -.
DR   OpenTargets; ENSG00000018510; -.
DR   Orphanet; 309803; Rhizomelic chondrodysplasia punctata type 3.
DR   PharmGKB; PA24624; -.
DR   eggNOG; KOG1233; Eukaryota.
DR   eggNOG; COG0277; LUCA.
DR   GeneTree; ENSGT00530000063515; -.
DR   HOGENOM; HOG000231620; -.
DR   HOVERGEN; HBG004179; -.
DR   InParanoid; O00116; -.
DR   KO; K00803; -.
DR   OMA; EIMKWNG; -.
DR   OrthoDB; EOG091G07KJ; -.
DR   PhylomeDB; O00116; -.
DR   TreeFam; TF313830; -.
DR   BioCyc; MetaCyc:HS00389-MONOMER; -.
DR   Reactome; R-HSA-75896; Plasmalogen biosynthesis.
DR   UniPathway; UPA00781; -.
DR   ChiTaRS; AGPS; human.
DR   GenomeRNAi; 8540; -.
DR   PRO; PR:O00116; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000018510; -.
DR   CleanEx; HS_AGPS; -.
DR   ExpressionAtlas; O00116; baseline and differential.
DR   Genevisible; O00116; HS.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005782; C:peroxisomal matrix; TAS:Reactome.
DR   GO; GO:0005778; C:peroxisomal membrane; IDA:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0008609; F:alkylglycerone-phosphate synthase activity; IDA:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; ISS:UniProtKB.
DR   GO; GO:0016614; F:oxidoreductase activity, acting on CH-OH group of donors; IEA:InterPro.
DR   GO; GO:0008611; P:ether lipid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0008610; P:lipid biosynthetic process; IDA:MGI.
DR   Gene3D; 1.10.45.10; -; 1.
DR   Gene3D; 3.30.43.10; -; 1.
DR   Gene3D; 3.30.465.10; -; 1.
DR   InterPro; IPR025650; Alkyl-DHAP_Synthase.
DR   InterPro; IPR016169; CO_DH_flavot_FAD-bd_sub2.
DR   InterPro; IPR016166; FAD-bd_2.
DR   InterPro; IPR016167; FAD-bd_2_sub1.
DR   InterPro; IPR016164; FAD-linked_Oxase-like_C.
DR   InterPro; IPR004113; FAD-linked_oxidase_C.
DR   InterPro; IPR006094; Oxid_FAD_bind_N.
DR   InterPro; IPR016171; Vanillyl_alc_oxidase_C-sub2.
DR   PANTHER; PTHR11748:SF107; PTHR11748:SF107; 1.
DR   Pfam; PF02913; FAD-oxidase_C; 1.
DR   Pfam; PF01565; FAD_binding_4; 1.
DR   SUPFAM; SSF55103; SSF55103; 2.
DR   SUPFAM; SSF56176; SSF56176; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cataract; Complete proteome; Disease mutation; Dwarfism;
KW   FAD; Flavoprotein; Lipid biosynthesis; Lipid metabolism; Membrane;
KW   Peroxisome; Phosphoprotein; Reference proteome;
KW   Rhizomelic chondrodysplasia punctata; Transferase; Transit peptide.
FT   TRANSIT       1     58       Peroxisome. {ECO:0000250}.
FT   CHAIN        59    658       Alkyldihydroxyacetonephosphate synthase,
FT                                peroxisomal.
FT                                /FTId=PRO_0000020431.
FT   DOMAIN      202    384       FAD-binding PCMH-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00718}.
FT   NP_BIND     234    240       FAD. {ECO:0000250}.
FT   NP_BIND     303    309       FAD. {ECO:0000250}.
FT   NP_BIND     316    319       FAD. {ECO:0000250}.
FT   NP_BIND     368    374       FAD. {ECO:0000250}.
FT   REGION      615    617       Important for enzyme activity.
FT                                {ECO:0000250}.
FT   COMPBIAS      2      8       Poly-Ala.
FT   ACT_SITE    578    578       Proton donor/acceptor. {ECO:0000250}.
FT   BINDING     515    515       Substrate. {ECO:0000250}.
FT   SITE        419    419       Important for enzyme activity.
FT                                {ECO:0000250}.
FT   MOD_RES      65     65       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      74     74       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     102    102       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     347    347       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VARIANT     182    182       R -> Q (in RCDP3; severely reduced
FT                                protein levels).
FT                                {ECO:0000269|PubMed:21990100}.
FT                                /FTId=VAR_066929.
FT   VARIANT     309    309       T -> I (in RCDP3; dbSNP:rs121434412).
FT                                {ECO:0000269|PubMed:11152660}.
FT                                /FTId=VAR_025895.
FT   VARIANT     419    419       R -> H (in RCDP3; dbSNP:rs121434411).
FT                                {ECO:0000269|PubMed:9553082}.
FT                                /FTId=VAR_005002.
FT   VARIANT     469    469       L -> P (in RCDP3; dbSNP:rs121434413).
FT                                {ECO:0000269|PubMed:11152660}.
FT                                /FTId=VAR_025896.
FT   VARIANT     471    471       E -> K (in RCDP3; severely reduced
FT                                protein levels).
FT                                {ECO:0000269|PubMed:21990100}.
FT                                /FTId=VAR_066930.
FT   VARIANT     568    568       T -> M (in RCDP3; does not affect protein
FT                                levels; dbSNP:rs387907214).
FT                                {ECO:0000269|PubMed:21990100}.
FT                                /FTId=VAR_066931.
SQ   SEQUENCE   658 AA;  72912 MW;  0E97AE86B513DF32 CRC64;
     MAEAAAAAGG TGLGAGASYG SAADRDRDPD PDRAGRRLRV LSGHLLGRPR EALSTNECKA
     RRAASAATAA PTATPAAQES GTIPKKRQEV MKWNGWGYND SKFIFNKKGQ IELTGKRYPL
     SGMGLPTFKE WIQNTLGVNV EHKTTSKASL NPSDTPPSVV NEDFLHDLKE TNISYSQEAD
     DRVFRAHGHC LHEIFLLREG MFERIPDIVL WPTCHDDVVK IVNLACKYNL CIIPIGGGTS
     VSYGLMCPAD ETRTIISLDT SQMNRILWVD ENNLTAHVEA GITGQELERQ LKESGYCTGH
     EPDSLEFSTV GGWVSTRASG MKKNIYGNIE DLVVHIKMVT PRGIIEKSCQ GPRMSTGPDI
     HHFIMGSEGT LGVITEATIK IRPVPEYQKY GSVAFPNFEQ GVACLREIAK QRCAPASIRL
     MDNKQFQFGH ALKPQVSSIF TSFLDGLKKF YITKFKGFDP NQLSVATLLF EGDREKVLQH
     EKQVYDIAAK FGGLAAGEDN GQRGYLLTYV IAYIRDLALE YYVLGESFET SAPWDRVVDL
     CRNVKERITR ECKEKGVQFA PFSTCRVTQT YDAGACIYFY FAFNYRGISD PLTVFEQTEA
     AAREEILANG GSLSHHHGVG KLRKQWLKES ISDVGFGMLK SVKEYVDPNN IFGNRNLL
//
